What is Xeomin®?
Botox® has been used worldwide for years to medically treat a number of muscular conditions, and cosmetically to remove wrinkles by temporarily blocking nerve activity in the muscles. It is made from a neurotoxin called Botulinum which is produced by the bacterium Clostridium botulinum.
Healthcare professionals now have access to Xeomin®, a commonly used product and an alternative to Botox®. Xeomin® (incobotulinumtoxinA) is also used for cosmetic purposes and to treat moderate wrinkles. It works as a great substitute for Botox® and is made from the same neurotoxin, therefore functioning in a similar manner.
Produced by Merz Pharmaceuticals, Xeomin® is approved by the United States Food and Drug Administration (FDA) with the conclusion that it is a safe and effective alternative to Botox®. It has now been approved for several cosmetic purposes.
Uses and Effects of Xeomin®
Given that Xeomin® is now readily available and FDA approved, it can be used both on-label and off-label by doctors for the treatment of facial lines and wrinkles treated by Botox®- including frown lines, crow’s feet and wrinkles on the forehead. Several thousands of people worldwide have been treated with Xeomin® injections and have been satisfied by its results.
If a patient has frown or forehead lines, smile lines around their eyes, crow’s feet or all of the aforementioned, receiving Xeomin® injections can help make them look less tired and more relaxed. Notable results vary depending on the area treated and often vary from person to person. With Xeomin®, patients can expect the wrinkles on their forehead and around their eyes to become smoother, brows to be lifted and eyelids to appear more opened. This in turn would make the overall facial expression seem to exude more relaxation and alertness- giving users results similar to Botox®.
Xeomin® vs. Botox®
The two products are similar, but professionals remain undecided about which one is the better alternative for the treatment of fine lines and wrinkles for several reasons.
Xeomin® is the first product of its kind that does not need to be refrigerated before use, which makes its distribution and preservation much easier. The effects of Xeomin® begin to show within a week, with the results lasting for a period ranging from three to six months, making it comparable to its counterpart in terms of duration of action.
The human body, in an act of self-protection, develops antibodies in response to a foreign invader and attacks. Theoretically, antibodies could prevent a neurotoxin from having its desired effects by simply destroying it. Xeomin® also has no additives like Botox® does- it only consists of botulinum toxin type A. This in turn considerably decreases the risk of one’s body to develop antibodies against Xeomin® than other available neurotoxins. If a patient has received Botox® and seemed to be dissatisfied with the results, their body may respond better to Xeomin®.
Things to keep in mind before using Xeomin®
Pregnant patients must avoid Xeomin® injections. Similarly, people that have any neurological disease, history of temporary paralysis, loss of vision, or double vision, should not receive Xeomin® injections. With these disorders, there may be an increased risk of complications and using this product could even worsen an underlying disorder.
Xeomin® must not be used interchangeably with other botulinum products. Using Xeomin® in a larger amount and more often than what is prescribed will not make it more effective and can result in serious side effects. In the case where one is allergic to botulinum toxin they should completely avoid receiving Xeomin®. Botulinum toxin could potentially spread to other areas of the body beyond where it was injected, possibly causing serious life-threatening side effects. Therefore, after a treatment, patients are advised to avoid laying back or falling asleep because the injected Xeomin® may spread to nearby areas causing unwanted and unpleasant relaxation of other muscles.
The Xeomin®-injected area may appear to be like a mosquito bite for up to an hour after and may remain swollen for a few hours. Skin may display redness around affected area, a symptom that is likely to last only a few days. After treatment, patients are likely to experience bruising. To prevent and minimize bruising after treatment, patients should avoid products containing aspirin or high-dose vitamin E supplements for up to ten days prior to the procedure. If bruising occurs, it may require around 7 to 10 days for it to clear up. Patients can apply makeup immediately after treatment which means they can easily conceal possible bruises. Health professionals should recommend their patients exercise the facial muscles several times for a few hours after the injections in order to speed up Xeomin® absorption. This can be done by frowning, raising the eyebrows, smiling, and squinting.
Xeomin® in the Future
Over the years, Xeomin® has become increasingly popular, especially since it has often proven more effective on people that do not get desired results from Botox®. With cosmetic procedures becoming more and more common, it seems that a larger number of healthcare professionals will turn to Xeomin® given its similarity to Botox® and the fact that it requires no prior refrigeration before administration. Time will allow professionals to understand and observe the notable differences between this product and its counterpart. It is not difficult to predict, however, that Xeomin® is soon going to be well adopted by professionals all over the world.
For more information on the IAPAM Aesthetic Medicine Symposium with Botox Training, please call 1-800-219-5108 x704 or e-mail us at: firstname.lastname@example.org
Botox is a trademark of Allergan Inc.; Xeomin is a trademark of Merz Aesthetics